Whether you’re working in an agency, in a clinical role, or in academia, many healthcare professionals wonder what lies behind the doors of the pharmaceutical industry.

In this episode, Gina is joined by Sian Kneller, Director of Global Content Design at GSK and Founder of The Agency Advantage, to unpack exactly what it takes to make the leap. With over 20 years’ experience, from medical writer to leading global medical affairs strategy, Sian now helps others make a successful move into pharma. In this episode she shares what the transition really looks like, which transferable skills matter most, and how you can stand out in a competitive field.

In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related diseases. From understanding the science behind cellular senescence to how senolytic drugs work and what early clinical trials reveal, this episode explores an exciting frontier in longevity medicine.

In this episode we explore the concept of syndemics, where biology, society and the environment intersect to shape health outcomes. Joined by Dr Elena Nikiphorou and Dr Lisa Hamzah, we explore how applying this framework, first developed in HIV research, could revolutionise care for people with rheumatic and musculoskeletal diseases (RMDs) and bring us closer to achieving global health equity.

We all know sleep is important, but what happens when physicians don’t get enough? In this episode of Visionary Voices, we’re joined by sleep expert Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. Grace studies how sleep impacts the health, safety and performance of shift workers. We explore the effects of sleep on physicians, patient outcomes and practical strategies to manage sleep deprivation.

The patient voice has become a pillar of medical education. In this episode, Nicky speaks with Tammy Gibbs, Managing Director at touchIME, about how including patient stories and perspectives can impact clinical practice. From enhancing empathy to improving patient outcomes, Tammy shares how touchIME is putting patients at the heart of education and why true collaboration between HCPs and patients matters.

Why do some children develop food allergies, but others don’t?

Preventing childhood food allergies has become an urgent priority as rates continue to rise worldwide. Now affecting around 6–8% of children globally, childhood food allergies have tripled over the past decades in high-income countries, leaving families and healthcare professionals searching for answers.

In this episode, we speak with leading paediatric allergist Prof. Helen Brough to explore the key factors behind why some children develop allergies to foods such as peanuts, why others do not. We look at the latest evidence on preventing childhood food allergies, with practical advice starting from pregnancy through to the first year of life and beyond. We also discuss the latest developments in managing food allergies and the innovations on the horizon that could transform how we treat and support children living with these conditions.

For more information on preventing food allergies in babies, Prof. Brough recently published a practical guide for parents which can be accessed here.

Onychomycosis, also known as a fungal nail infection, is one of the most common nail conditions seen in clinical practice, yet diagnosis is often uncertain and treatment failures are frustratingly common. In this episode, Dr Shari Lipner shares practical updates on smarter diagnostics, existing & emerging therapies and what we need to know about how to manage this condition with more confidence today and in the future.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many doctors are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more supportive healthcare culture.

Did you know that the number of people aged 65 and older living with Alzheimer’s disease in the US is expected to double by 2050? In this episode of Visionary Voices, Dr Anthony Caggiano, Chief Medical Officer at Cognition Therapeutics, explores how biomarkers are transforming our understanding of Alzheimer’s disease, from diagnosis and disease progression to drug development and the future of clinical care.

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.